tiprankstipranks
Trending News
More News >
Unicycive Therapeutics, Inc. (UNCY)
:UNCY
US Market

Unicycive Therapeutics (UNCY) Income Statement

Compare
600 Followers

Unicycive Therapeutics Income Statement

Last quarter (Q1 2025), Unicycive Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Unicycive Therapeutics's net income was $570.00K. See Unicycive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 675.00K$ 944.00K$ -1.00K$ 0.00
Operating Expenses
$ 32.12M$ 21.45M$ 19.00M$ 8.98M$ 2.02M
Depreciation and Amortization
$ 428.00K$ 284.00K$ 7.00K$ 1.00K$ 2.02M
EBITDA
$ -36.23M$ -30.18M$ -18.05M$ -8.98M$ 0.00
Operating Income
$ -32.12M$ -20.77M$ -18.05M$ -8.98M$ -2.02M
Other Income/Expenses
$ -5.71M$ -9.77M$ -6.00K$ -1.04M$ -244.00K
Pretax Income
$ -37.82M$ -30.54M$ -18.06M$ -10.02M$ -2.26M
Net Income
$ -36.73M$ -30.54M$ -18.06M$ -10.63M$ -2.51M
Per Share Metrics
Basic EPS
$ -0.06$ -1.28$ -1.20$ -0.71$ -0.16
Diluted EPS
$ -0.06$ -1.28$ -1.20$ -0.71$ -0.16
Weighted Average Shares Outstanding
669.85M 24.54M 15.06M 15.00M 15.25M
Weighted Average Shares Outstanding (Diluted)
669.85M 24.54M 15.06M 15.00M 15.25M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis